StockGlow

UroGen Pharma Ltd. (UR8.F)

UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization of solutions for urothelial and specialty cancers.

35.07+0.02%Healthcare
Compare UR8.F with
StockGlow Score
92
Bullish
BearishBullish
1 year ago+116.5%

The outlook

UroGen Pharma Ltd. currently reads as bullish based on above its 50- & 200-day averages, 88% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendAbove its 50- & 200-day averages
52-week range88% of the way from its 52-week low to high
Market cap
$1.71B
52-wk high
37.95
52-wk low
13.80
50-day avg
29.44
200-day avg
21.23
Trailing P/E
—

Similar stocks

UKJ0.FCeryvyn Therapeutics Limited$0.01+16.00%BO1.FBioCryst Pharmaceuticals, Inc.$8.03-2.48%3O8.FOmeros Corporation$10.20+0.49%C1S.FChina Shineway Pharmaceutical Group Limited$0.89-2.75%C1P.FConsun Pharmaceutical Group Limited$1.50+0.00%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy